ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $8,657,000 | +45.0% | 186,852 | -23.7% | 0.01% | +40.0% |
Q1 2019 | $5,972,000 | +161.5% | 244,942 | +52.8% | 0.01% | +150.0% |
Q4 2018 | $2,284,000 | -34.0% | 160,292 | -29.6% | 0.00% | -33.3% |
Q3 2018 | $3,462,000 | -12.9% | 227,758 | -3.8% | 0.00% | -25.0% |
Q2 2018 | $3,973,000 | +17.3% | 236,776 | +14.0% | 0.00% | +33.3% |
Q1 2018 | $3,388,000 | +47.8% | 207,628 | +15.9% | 0.00% | +50.0% |
Q4 2017 | $2,293,000 | +12.7% | 179,166 | +8.3% | 0.00% | 0.0% |
Q3 2017 | $2,034,000 | +316.8% | 165,368 | +183.4% | 0.00% | +100.0% |
Q2 2017 | $488,000 | -9.0% | 58,352 | -2.7% | 0.00% | 0.0% |
Q1 2017 | $536,000 | +36.0% | 59,988 | +33.9% | 0.00% | 0.0% |
Q4 2016 | $394,000 | -16.5% | 44,798 | -35.9% | 0.00% | 0.0% |
Q3 2016 | $472,000 | +67.4% | 69,888 | -11.7% | 0.00% | – |
Q2 2016 | $282,000 | +40.3% | 79,142 | +16.3% | 0.00% | – |
Q1 2016 | $201,000 | -30.4% | 68,059 | -0.6% | 0.00% | – |
Q4 2015 | $289,000 | +35.0% | 68,504 | +45.8% | 0.00% | – |
Q3 2015 | $214,000 | +11.5% | 46,985 | +76.0% | 0.00% | – |
Q2 2015 | $192,000 | -3.5% | 26,696 | -1.1% | 0.00% | – |
Q1 2015 | $199,000 | +51.9% | 26,993 | -2.8% | 0.00% | – |
Q4 2014 | $131,000 | +28.4% | 27,757 | -3.2% | 0.00% | – |
Q3 2014 | $102,000 | -13.6% | 28,665 | +14.6% | 0.00% | – |
Q1 2014 | $118,000 | -7.1% | 25,013 | -1.3% | 0.00% | – |
Q4 2013 | $127,000 | -19.1% | 25,341 | +0.7% | 0.00% | – |
Q3 2013 | $157,000 | +38.9% | 25,169 | +1.1% | 0.00% | – |
Q2 2013 | $113,000 | – | 24,897 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |